Christopher Peetz, President and CEO at Mirum Pharmaceuticals, Inc. (MIRM), bought 8,000 shares at $18.76 ($150K) on 2020-12-23, disclosed to the SEC on 2020-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.60 | 2,000 | $37K | 24.8% |
| 2 | $18.76 | 3,000 | $56K | 37.6% |
| 3 | $18.76 | 3,000 | $56K | 37.6% |
| Total | $18.72 avg | 8,000 | $150K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |